Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention

被引:44
作者
Arca, M. [1 ]
Borghi, C. [2 ]
Pontremoli, R. [3 ]
De Ferrari, G. M. [4 ,5 ]
Colivicchi, F. [6 ]
Desideri, G. [7 ]
Temporelli, P. L. [8 ]
机构
[1] Sapienza Univ Roma, Dipartimento Med Interna & Specialita Med, Viale Policlin 155, I-00161 Rome, Italy
[2] Univ Bologna, Osped Policlin S Orsola Malpighi, Dipartimento Sci Med & Chirurg, Bologna, Italy
[3] Univ Genoa, Osped Policlin San Martino, Dipartimento Med Interna, Genoa, Italy
[4] Univ Pavia, Unita Coronar, Ctr Clin Ric Cardiovasc, Dipartimento Med Mol,IRCCS Fdn Policlin San Matte, Pavia, Italy
[5] Univ Pavia, Lab Sperimentaz & Ric, Ctr Clin Ric Cardiovasc, Dipartimento Med Mol,IRCCS Fdn Policlin San Matte, Pavia, Italy
[6] ASL ROMA 1, UOC Cardiol, Osped S Filippo Neri, Rome, Italy
[7] Univ Aquila, Fac Med & Chirurg, Laquila, Italy
[8] IRCCS, ICS Maugeri, Div Cardiol Riabilitat, Veruno, NO, Italy
关键词
Cardiovascular disease; Triglycerides; Hypertriglyceridemia; Omega-3 fatty acids; N-3; FATTY-ACIDS; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; PLACEBO-CONTROLLED TRIAL; NONFASTING TRIGLYCERIDES; FISH-OIL; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; SECONDARY PREVENTION;
D O I
10.1016/j.numecd.2017.11.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: This review aims to describe the pathogenic role of triglycerides in cardiometa-bolic risk, and the potential role of omega-3 fatty acids in the management of hypertriglyceridemia and cardiovascular disease. Data synthesis: In epidemiological studies, hypertriglyceridemia correlates with an increased risk of cardiovascular disease, even after adjustment for low density lipoprotein cholesterol (LDL-C) levels. This has been further supported by Mendelian randomization studies where triglyceride-raising common single nucleotide polymorphisms confer an increased risk of developing cardiovascular disease. Although guidelines vary in their definition of hypertriglyceridemia, they consistently define a normal triglyceride level as <150 mg/dL (or <1.7 mmol/L). For patients with moderately elevated triglyceride levels, LDL-C remains the primary target for treatment in both European and US guidelines. However, since any triglyceride level in excess of normal increases the risk of cardiovascular disease, even in patients with optimally managed LDL-C levels, triglycerides are an important secondary target in both assessment and treatment. Dietary changes are a key element of first-line lifestyle intervention, but pharmacological treatment including omega-3 fatty acids may be indicated in people with persistently high triglyceride levels. Moreover, in patients with pre-existing cardiovascular disease, omega-3 supplements significantly reduce the risk of sudden death, cardiac death and myocardial infarction and are generally well tolerated. Conclusions: Targeting resistant hypertriglyceridemia should be considered as a part of clinical management of cardiovascular risk. Omega-3 fatty acids may represent a valuable resource to this aim. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico IIUniversity. Published by Elsevier B.V.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 70 条
[1]   Hypertriglyceridemia Influences the Degree of Postprandial Lipemic Response in Patients with Metabolic Syndrome and Coronary Artery Disease: From the Cordioprev Study [J].
Alcala-Diaz, Juan F. ;
Delgado-Lista, Javier ;
Perez-Martinez, Pablo ;
Garcia-Rios, Antonio ;
Marin, Carmen ;
Quintana-Navarro, Gracia M. ;
Gomez-Luna, Purificacion ;
Camargo, Antonio ;
Almaden, Yolanda ;
Caballero, Javier ;
Tinahones, Francisco J. ;
Ordovas, Jose M. ;
Perez-Jimenez, Francisco ;
Lopez-Miranda, Jose .
PLOS ONE, 2014, 9 (05)
[2]   2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].
Catapano, Alberico L. ;
Graham, Ian ;
De Backer, Guy ;
Wiklund, Olov ;
Chapman, M. John ;
Drexel, Heinz ;
Hoes, Arno W. ;
Jennings, Catriona S. ;
Landmesser, Ulf ;
Pedersen, Terje R. ;
Reiner, Zeljko ;
Riccardi, Gabriele ;
Taskinen, Marja-Riita ;
Tokgozoglu, Lale ;
Verschuren, W. M. Monique ;
Vlachopoulos, Charalambos ;
Wood, David A. ;
Luis Zamorano, Jose .
ATHEROSCLEROSIS, 2016, 253 :281-344
[3]   The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia [J].
Backes, James ;
Anzalone, Deborah ;
Hilleman, Daniel ;
Catini, Julia .
LIPIDS IN HEALTH AND DISEASE, 2016, 15
[4]   Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials [J].
Birjmohun, RS ;
Hutten, BA ;
Kastelein, JJP ;
Stroes, ESG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (02) :185-197
[5]   Effect of Long-Chain ω-3 Fatty Acids and Lutein plus Zeaxanthin Supplements on Cardiovascular Outcomes Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial [J].
Bonds, Denise E. ;
Harrington, Molly ;
Worrall, Bradford B. ;
Bertoni, Alain G. ;
Eaton, Charles B. ;
Hsia, Judy ;
Robinson, Jennifer ;
Clemons, Traci E. ;
Fine, Lawrence J. ;
Chew, Emily Y. .
JAMA INTERNAL MEDICINE, 2014, 174 (05) :763-771
[6]   n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia [J].
Bosch, Jackie ;
Gerstein, Hertzel C. ;
Dagenais, Gilles R. ;
Diaz, Rafael ;
Dyal, Leanne ;
Jung, Hyejung ;
Maggiono, Aldo P. ;
Probstfield, Jeffrey ;
Ramachandran, Ambady ;
Riddle, Matthew C. ;
Ryden, Lars E. ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04) :309-318
[7]  
Bradberry J Chris, 2013, P T, V38, P681
[8]   Chylomicronaemia-current diagnosis and future therapies [J].
Brahm, Amanda J. ;
Hegele, Robert A. .
NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (06) :352-362
[9]   Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials [J].
Casula, Manuela ;
Soranna, Davide ;
Catapano, Alberico L. ;
Corrao, Giovanni .
ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (02) :243-251
[10]   CHYLOMICRONEMIA SYNDROME IN DIABETES-MELLITUS [J].
CHAIT, A ;
ROBERTSON, HT ;
BRUNZELL, JD .
DIABETES CARE, 1981, 4 (03) :343-348